Advanced Imaging for Localized Prostate Cancer
Cancers · 15.10.2024 · 16 (20) · 3490
DOI: 10.3390/cancers16203490 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.10.2024. Verfasst von Patrick Albers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB T6G 1Z2, Canada. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital Foundation, Alberta Cancer Foundation.
Abstract (Originalsprache)
Background/Objectives: Prostate cancer is a prevalent malignancy often presenting without early symptoms. Advanced imaging technologies have revolutionized its diagnosis and management. This review discusses the principles, benefits, and clinical applications of multiparametric magnetic resonance imaging (mpMRI), micro-ultrasound (microUS), and prostate-specific membrane antigen positron emission tomography–computed tomography (PSMA PET/CT) in localized prostate cancer.
Methods
We conducted a comprehensive literature review of recent studies and guidelines on mpMRI, microUS, and PSMA PET/CT in prostate cancer diagnosis, focusing on their applications in biopsy-naïve patients, those with previous negative biopsies, and patients under active surveillance.
Results
MpMRI has demonstrated high sensitivity and negative predictive value in detecting clinically significant prostate cancer (csPCa). MicroUS, a newer technology, has shown promising results in early studies, with sensitivity and specificity comparable to mpMRI. PSMA PET/CT has emerged as a highly sensitive and specific imaging modality, particularly valuable for staging and detecting metastatic disease. All three technologies have been incorporated into urologic practice for prostate cancer diagnosis and management, with each offering unique advantages in different clinical scenarios.
Conclusions
Advanced imaging techniques, including mpMRI, microUS, and PSMA PET/CT, have significantly improved the accuracy of prostate cancer diagnosis, staging, and management. These technologies enable more precise targeting of suspicious lesions during biopsy and therapy planning. However, further research, especially randomized controlled trials, is needed to fully establish the optimal use and inclusion of these imaging modalities in various stages of prostate cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
- Alberta Prostate Cancer Research Initiative (APCaRI), Edmonton, AB T6G 1Z2, Canada.
- Cancer Research Institute of Northern Alberta (CRINA), Edmonton, AB T6G 2E1, Canada.
- Alberta Center for Urologic Research and Excellence (ACURE), Edmonton, AB T6G 1Z2, Canada.
- Department of Oncology, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
ORCID-Profile: Patrick Albers
Förderung
- University Hospital Foundation
- Alberta Cancer Foundation
Zitieren
APA
Albers, P., & Kinnaird, A. (2024). Advanced Imaging for Localized Prostate Cancer. Cancers, 16(20), 3490. https://doi.org/10.3390/cancers16203490
Vancouver
Albers P, Kinnaird A. Advanced Imaging for Localized Prostate Cancer. Cancers. 2024;16(20):3490. doi:10.3390/cancers16203490
BibTeX
@article{Albers2024,
author = {Albers, Patrick and Kinnaird, Adam},
title = {Advanced Imaging for Localized Prostate Cancer},
journal = {Cancers},
year = {2024},
volume = {16},
number = {20},
pages = {3490},
doi = {10.3390/cancers16203490}
}
EUVIMED